Every SEC Form 3/4/5 on record for this filer (CIK 1591046) — 6 issuers, 14 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | 10% owner · lapsed | 2023-11-02 → 2023-11-09 | 2 | $2M |
| IOBT | IO Biotech, Inc. | Director · lapsed | 2021-11-04 → 2023-08-11 | 3 | $30M |
| IMRA | IMARA Inc. | 10% owner · lapsed | 2020-03-11 → 2020-03-16 | 2 | $3M |
| TRVI | Trevi Therapeutics, Inc. | 10% owner · lapsed | 2019-05-07 → 2019-05-13 | 2 | $4M |
| SCPH | scPharmaceuticals Inc. | 10% owner · lapsed | 2017-11-16 → 2017-11-21 | 2 | $9M |
| SPRO | Spero Therapeutics, Inc. | 10% owner · lapsed | 2017-11-01 → 2017-11-01 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| LXEO | 2023-11-07 | Buy | 227,272 | $11.00 | $2M | 1,835,959 |
| IOBT | 2021-11-09 | Buy | 2,142,857 | $14.00 | $30M | 6,049,452 |
| IMRA | 2020-03-16 | Buy | 187,500 | $16.00 | $3M | 1,432,722 |
2 of 6 issuers are covered and open a security page; the rest are on file here only.
